158 related articles for article (PubMed ID: 4022426)
1. [Gastrointestinal cancer antigen and carcinoembryonic antigen in chronic pancreatopathies and pancreatic tumors].
Piantino P; Cerchier A; Tappero GF; Pecchio F; Ghisetti V
Minerva Med; 1985 Jul; 76(28-29):1331-4. PubMed ID: 4022426
[TBL] [Abstract][Full Text] [Related]
2. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
Tappero G; Piantino P; Cerchier A; Pecchio F
Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
[TBL] [Abstract][Full Text] [Related]
3. [Preoperative elevation of CEA, CA 19-9 and CA 50 in the inoperable stages of colorectal cancer].
Lamíquiz Vallejo A; Loizate Totoricagüena A; Domínguez Merru-Urrutia MJ
Rev Esp Enferm Apar Dig; 1988 Mar; 73(3):323-4. PubMed ID: 2453075
[No Abstract] [Full Text] [Related]
4. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
[TBL] [Abstract][Full Text] [Related]
5. [Tumor antigens CA 125 and CA l9-9 in the serum of patients with gynecologic trophoblastic tumors and colorectal carcinoma].
Göcze P; Szabó D; Than G; Csaba I; Krommer K
Orv Hetil; 1986 Aug; 127(35):2123-6. PubMed ID: 3024089
[No Abstract] [Full Text] [Related]
6. [Studies on serum CEA levels measured by enzyme immunoassay using monoclonal CEA-antibodies].
Takada S; Hoshi H; Ito F; Imai K; Yachi A
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1487-91. PubMed ID: 6378102
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E
Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases].
Czakó L; Takács T; Babarczy E; Dux L; Lonovics J
Orv Hetil; 1997 Nov; 138(47):2981-5. PubMed ID: 9432648
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
10. [New monoclonal antibodies in the diagnosis of gastrointestinal cancers].
Heptner G; Domschke S; Domschke W
Internist (Berl); 1986 Nov; 27(11):723-8. PubMed ID: 2433247
[No Abstract] [Full Text] [Related]
11. Comparison of portal and peripheral blood levels of carcinoembryonic antigen, CA 19-9, and CA 125 tumor-associated antigens in patients with colorectal and pancreatic cancer.
Talbot RW; Nagorney DM; Pemberton JH; Wieand HS; Ritts RE
Cancer Res; 1989 Feb; 49(3):542-3. PubMed ID: 2910474
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody to a human pancreatic carcinoma cell line recognizes gastrointestinal neoplasms.
Kahn HJ; Yeger H; Loftus R; Goldrosen MH
Am J Pathol; 1989 Mar; 134(3):641-9. PubMed ID: 2466406
[TBL] [Abstract][Full Text] [Related]
14. [Comparison between stool CEA and serum CEA in colorectal cancer measured by monoclonal anti-CEA antibody].
Ishii K; Takemura K; Endo M
Nihon Geka Gakkai Zasshi; 1985 Aug; 86(8):972. PubMed ID: 3903470
[No Abstract] [Full Text] [Related]
15. Immunohistochemical antigenic expression and in vivo tumor uptake of monoclonal antibodies with specificity for tumors of the gastrointestinal tract.
Douillard JY; Lehur PA; Aillet G; Kremer M; Bianco-Arco A; Peltier P; Chatal JF
Cancer Res; 1986 Aug; 46(8):4221-4. PubMed ID: 3524803
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies for carcinoembryonic antigen (CEA) as a model system: identification of two novel CEA-related antigens in meconium and colorectal carcinoma tissue by Western blots and differential immunoaffinity chromatography.
Neumaier M; Fenger U; Wagener C
J Immunol; 1985 Nov; 135(5):3604-9. PubMed ID: 4045198
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
Ozkan H; Kaya M; Cengiz A
Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
[TBL] [Abstract][Full Text] [Related]
18. [Recent progress in tumor markers of the digestive system].
Mori T
Gan No Rinsho; 1983 May; 29(6):663-71. PubMed ID: 6876437
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.
Chester KA; Begent RH
Clin Exp Immunol; 1984 Dec; 58(3):685-93. PubMed ID: 6509799
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic applications of monoclonal antibodies to human cancer.
Borowitz MJ; Stein RB
Arch Pathol Lab Med; 1984 Feb; 108(2):101-5. PubMed ID: 6546490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
